- Home
- JKS vs MDXG Comparison
JKS vs MDXG Comparison
Compare JKS & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JKS
- MDXG
- Stock Information
- Founded
- JKS 2006
- MDXG 2006
- Country
- JKS China
- MDXG United States
- Employees
- JKS N/A
- MDXG N/A
- Industry
- JKS Semiconductors
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- JKS Technology
- MDXG Health Care
- Exchange
- JKS Nasdaq
- MDXG Nasdaq
- Market Cap
- JKS 1.3B
- MDXG 1.1B
- IPO Year
- JKS 2010
- MDXG N/A
- Fundamental
- Price
- JKS $22.46
- MDXG $7.14
- Analyst Decision
- JKS Hold
- MDXG Buy
- Analyst Count
- JKS 5
- MDXG 1
- Target Price
- JKS $27.19
- MDXG $12.00
- AVG Volume (30 Days)
- JKS 416.6K
- MDXG 786.1K
- Earning Date
- JKS 09-09-2025
- MDXG 07-30-2025
- Dividend Yield
- JKS 6.35%
- MDXG N/A
- EPS Growth
- JKS N/A
- MDXG N/A
- EPS
- JKS N/A
- MDXG 0.21
- Revenue
- JKS $11,445,691,729.00
- MDXG $363,774,000.00
- Revenue This Year
- JKS N/A
- MDXG $9.55
- Revenue Next Year
- JKS $31.21
- MDXG $11.43
- P/E Ratio
- JKS N/A
- MDXG $33.94
- Revenue Growth
- JKS N/A
- MDXG 6.85
- 52 Week Low
- JKS $13.42
- MDXG $5.47
- 52 Week High
- JKS $37.36
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- JKS 54.16
- MDXG 55.66
- Support Level
- JKS $22.09
- MDXG $7.04
- Resistance Level
- JKS $24.37
- MDXG $7.39
- Average True Range (ATR)
- JKS 0.87
- MDXG 0.19
- MACD
- JKS 0.10
- MDXG -0.02
- Stochastic Oscillator
- JKS 63.98
- MDXG 57.59
About JKS JinkoSolar Holding Company Limited (each representing 4)
JinkoSolar Holding Co Ltd is engaged in the photovoltaic industry. The firm has built a vertically integrated solar power product value chain, manufacturing from silicon wafers to solar modules. It sells solar modules under the JinkoSolar brand. The company's products include Silicon wafers, Solar cells, and Solar modules. Its geographical segments are China (including Hong Kong and Taiwan), North America, Europe, Asia Pacific, and the Rest of the world.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.